RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Revenue of RPG Life Sciences Limited (RPGLIFE.NS)
Revenue in 2023 (TTM): $68.96 M
According to RPG Life Sciences Limited's latest financial reports the company's current revenue (TTM) is $68.96 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of RPG Life Sciences Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $68.96 M | $29.42 M | $15.18 M | $13.96 M | $10.39 M |
| 2022 | $60.76 M | $40.51 M | $12.83 M | $10.86 M | $8.01 M |
| 2021 | $51.79 M | $34 M | $10.69 M | $8.67 M | $6.1 M |
| 2020 | $45.42 M | $29.12 M | $8.51 M | $6.35 M | $4.74 M |
| 2019 | $43.74 M | $28.6 M | $6.58 M | $4.32 M | $3.44 M |
| 2018 | $38.38 M | $25.34 M | $4.17 M | $1.78 M | $1.28 M |
| 2017 | $39.94 M | $26.37 M | $4.67 M | $2.41 M | $1.59 M |
| 2016 | $36.29 M | $23.75 M | $3.49 M | $2.69 M | $2.42 M |
| 2015 | $33.05 M | $22.21 M | $2.87 M | $1.38 M | $1.38 M |
| 2014 | $28.7 M | $18.67 M | $1.68 M | $118.48 K | $118.48 K |
| 2013 | $27.88 M | $18.79 M | $1.84 M | $7.7 M | $6.33 M |
| 2012 | $26.26 M | $17.2 M | $2.11 M | $63.98 K | $522.49 K |
| 2011 | $22.84 M | $16.3 M | $2.23 M | $206.15 K | $100.71 K |
| 2010 | $21.82 M | $15.93 M | $3.88 M | $2.07 M | $1.51 M |
| 2009 | $18.94 M | $13.43 M | $3.78 M | $1.72 M | $1.28 M |
| 2008 | $16.64 M | $11.64 M | $3.12 M | $984.96 K | $782.84 K |
| 2007 | $15.13 M | $10.49 M | $3.03 M | $1.1 M | $705.36 K |
| 2006 | $14.25 M | $9.28 M | $3.13 M | $1.18 M | $952.26 K |